Methyl2-(4-benzyloxy-3-bromo-5-formyl-phenyl)acetate, 98%, 5g

1-(2-Chloropyridine-3-carbonyl)-4-piperidinone, 97.0%, 1g

(R)-(2,2-Difluorocyclopropyl)methanol, 98%, 500mg

N-Benzylacetamide, 99.0%, 100g

3-Chloro-5-fluorophenylacetylene, 250mg

Anthracene, >=96%, for synthesis, 100 g, plastic packaging.

5-(4-Chloro-phenoxymethyl)-furan-2-carboxylic acid, 95.0%, 5g

2-(2-Aminophenyl)acetonitrile, 95.0%, 1g

3-[[3,5-Bis(trifluoromethyl)phenyl]amino]-4-[[(1R,2R)-2-(dimethylamino)-1,2-diphenylethyl]amino]-3-cyclobutene-1,2-dione, 97%, 250mg

2-Bromothieno[3,2-c]pyridine, 95.0%, 250mg

2,6-Dibromo-4-methoxypyridine, 95.0%, 25g

Benzenesulfonyl Chloride [for Determination of Hippuric Acid]>99.0%(GC)(T)25g

(R)-3-Hydroxypiperidin-2-one, 95+%, 1g